My lab’s vision for the next five years is to apply what we have learned to develop molecules that can alter FA protein behavior. These could be used to treat cancer or alter gene editing outcomes.
Directory
![](https://fanconi.org/wp-content/uploads/2018/11/Lisa-Mingo-1249-1656528250.jpg)
Lisa Mingo
President | CPA, CPHR
Mother of Dylan
Lisa joined the Fanconi anemia “FAmily” in 2007, when her 5-month-old son, Dylan, was diagnosed with FA. A world traveler, Lisa has a love of meeting new people and experiencing other cultures. She has lived and worked in four continents and currently lives in Vancouver, Canada with her New Zealand-born husband, Mark, and their two boys, Connor and Dylan. As a Canadian CPA (Chartered Professional Accountant) and CPHR (Chartered Professional of Human Resources), Lisa has experience working across a variety of industries in the Finance, HR, IT and Project Management spaces.
Presently, she owns and operates a small architectural practice with her husband. Lisa is looking forward to her continued involvement in progressing FA research as a board member and fundraiser. She and her family have held community-based fundraisers in Vancouver since 2011. Of particular interest to her is expanding FCF’s connection to the international community.
The Latest
News & Events
![](https://fanconi.org/wp-content/uploads/2024/06/IMG_1499s-scaled-e1718991245321-1024x554.jpg)
![](https://fanconi.org/wp-content/uploads/2024/06/Omar7-778x1024.png)
In a world where every day presents new challenges, my 11-year-old son, Omar, from Oman, stands out for his resilience and eagerness to raise awareness about Fanconi anemia. Diagnosed at just five years old, we truly believe his journey is a testament to hope and the strength of the human spirit.
![](https://fanconi.org/wp-content/uploads/2024/04/Copy-of-FCF-Social-Media-Templates-1024x1024.png)
That's why we're thrilled to announce the launch of the Fanconi Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research, a flagship funding opportunity in partnership with the American Association for Cancer Research (AACR).